Showing results (471-480 of 1,177) with videos related to
Sort By:
Pageof 118
Applied Health Economics and Health Policy|September 18, 2020
Budget Impact of Microbial Cell-Free DNA Testing Using the Karius® Test as an Alternative to Invasive Procedures in Immunocompromised Patients with Suspected Invasive Fungal InfectionsAnn T MacIntyre, Alex Hirst, Radha Duttagupta, et al.Applied Health Economics and Health Policy|June 9, 2021
Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?Patricia Cubi-Molla, Martin Buxton, Nancy DevlinApplied Health Economics and Health Policy|July 13, 2022
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and ScotlandDaniel Tobias Michaeli, Mackenzie Mills, Panos KanavosApplied Health Economics and Health Policy|February 3, 2016
The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A NICE Medical Technology GuidanceAlistair Ray, Helen Morgan, Antony Wilkes, et al.Applied Health Economics and Health Policy|January 1, 2016
The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke's Encephalopathy Presenting at the Emergency DepartmentEdward C F Wilson, George Stanley, Zulfiquar MirzaApplied Health Economics and Health Policy|January 29, 2016
The TURis System for Transurethral Resection of the Prostate: A NICE Medical Technology GuidanceAndrew Cleves, Paul Dimmock, Neil Hewitt, et al.Applied Health Economics and Health Policy|October 3, 2014
Health technology assessment of cancer drugs in Canada, the United Kingdom and Australia: should the United States take notice?George Dranitsaris, George PapadopoulosApplied Health Economics and Health Policy|September 20, 2015
Estimating the Costs of Torture: Challenges and OpportunitiesEmmanuel Kabengele Mpinga, Ngianga-Bakwin Kandala, Jennifer Hasselgård-Rowe, et al.Applied Health Economics and Health Policy|September 4, 2015
A Systematic Review of Health Economic Evaluations of Diagnostic BiomarkersMarije Oosterhoff, Marloes E van der Maas, Lotte M G SteutenApplied Health Economics and Health Policy|July 17, 2014
Ethical objections against including life-extension costs in cost-effectiveness analysis: a consistent approachAfschin Gandjour, Dirk MüllerPageof 118